Evidence map›Paper›PMID 33036741›Full record

Observational studyBulletin du cancer2020

[Non endometroid endometrial cancer guidelines evaluation: A multicentric retrospective study].

Antoine Scattarelli, Albane Poteau, Moutaz Aziz, Marick Lae, Philippe Courville, Maxime Arnaud, Loic Marpeau, Benoit Resch

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Bulletin du cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Antoine ScattarelliDépartement de chirurgie gynécologique, CHU Rouen, 37, boulevard Gambetta, 76000 Rouen, France. Electronic address: antoine.scattarelli@gmail.com.
Albane PoteauDépartement de chirurgie, CLCC Henri Becquerel, Rue d'Amiens, Rouen, France.
Moutaz AzizDépartement d'anatomopathologie, CHU Rouen, Boulevard Gambetta, Rouen, France.
Marick LaeDépartement d'anatomopathologie, CLCC Henri Becquerel, Rue d'Amiens, Rouen, France.
Philippe CourvilleDépartement d'anatomopathologie, laboratoire rue Verte, Rue Verte, Rouen, France.
Maxime ArnaudDépartement d'anatomopathologie, clinique Europe, Boulevard de l'Europe , Rouen, France.
Loic MarpeauDépartement de chirurgie gynécologique, CHU Rouen, 37, boulevard Gambetta, 76000 Rouen, France.
Benoit ReschDépartement de chirurgie gynécologique, clinique Mathilde, Boulevard de l'Europe, Rouen, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNon endometrioid endometrial cancer are infrequent and have poor prognosis. The aim of the study was to evaluate non endometrioid endometrial cancer managment by evaluating endometrial cancer guidelines application. MATERIAL AND

methodsThis multicentric retrospective study enrolled non endometrioid endometrial cancer between January 2009 to December 2019. Analyses adapted at last French guidelines applicated corresponding of year management.

resultsSeventy-four non endometrioid endometrial cancer analysed in 10 centers: 34 carcinosarcoma (45,9 %), 29 serous carcinoma (39,2 %), 9 clear cells carcinoma (12,2 %) and 2 undifferentiated carcinoma (2,7 %). For initial management, endometrial cancer guidelines applicated to 45,9 %. First reason of initial guidelines « non-application » was lack of surgical lymph node stadification (57,1 %). For adjuvant management, endometrial cancer guidelines applicated to 38.7 %. First reason of adjuvant guidelines « non-application » was lack lymph node stadification to complete staging when it previously incompletly operated (67,6 %). DISCUSSION: Non endometrioid endometrial cancer guidelines applicability is difficult. This explicated by high age and comorbidity when surgical lymph node stadification is necessary. Using new staging technic will allow target management and better select lymph node staging indication.

Indexed as

Adenocarcinoma, Clear CellCarcinosarcomaCystadenocarcinoma, SerousEndometrial NeoplasmsGuideline AdherenceAgedAged, 80 and overFemaleFranceHumansMetrorrhagiaMiddle AgedNeoplasm SeedingPractice Guidelines as TopicPrognosisRetrospective StudiesApplicationCancer endomètreEndometrial cancerGuidelinesManagementNon-endometrioidNon-endométrioïdeRecommandations

Identifiers

PMID33036741
PMCPMC7537627

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.